Melanotan II vs PT-141
Updated 9 sources
Key differences
- 1Both are cyclic 7-amino-acid melanocortin agonists. MT-II hits MC1R, MC3R, MC4R and MC5R, so it tans, raises libido and cuts appetite at once.
- 2PT-141 (bremelanotide) favours MC3R/MC4R, tans little, and is FDA approved as Vyleesi for low desire in women. MT-II was never submitted for approval.
- 3PT-141 is used on demand; MT-II is loaded daily and then dosed weekly.
- 4Same melanocortin family. Melanotan II hits the receptors broadly and tans strongly.
- 5PT-141 was chosen to keep the sexual effect with less tanning, but dark patches still show up: 1% at label use, 38% after 8 daily doses.
Side by side
Facts from each record, in the same words as their own pages.
| Melanotan II | PT-141 | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
9 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Regulatory4
- Vyleesi (bremelanotide) prescribing information, 2019FDA · checked Oct 23, 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · checked Oct 24, 2026
- Notice proposing permanent debarment, Docket FDA-2015-N-4169 (Melanocorp)FDA · checked Oct 24, 2026
- Vyleesi label (current)DailyMed · checked Oct 23, 2026
Competitor guide5
- Melanotan 2 (MT-2) Peptide Guide: Dosing, Reconstitution & Safety (2026)peptidedosingprotocols.com · checked Oct 24, 2026
- Melanotan II: Benefits, Dosage & Side Effectspeptidesexplorer.com · checked Oct 24, 2026
- Bremelanotide (PT-141) protocolpeptidedosingprotocols.com · checked Oct 23, 2026
- Melanotan II: Dosing, Side Effects & FDA Statuspeptiq.io · checked Oct 24, 2026